Case Series of Guillain-Barre Syndrome After the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) Vaccine. Wan MM, Lee A, Kapadia R, Hahn C, et al. Neurol Clin Pract 2022;12:149-153.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wan MM, Lee A, Kapadia R, Hahn C, et al. Case Series of Guillain-Barre Syndrome After the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) Vaccine. Neurol Clin Pract 2022;12:149-153.
PMID: 35747886